NPR: What A Difference A Drug Makes In The Fight Against River Blindness
“…[O]ver the past three decades, much of the world has made steady progress against the debilitating condition. And much of the credit for that progress is linked to ministries of health introducing the drug ivermectin. Mass distributions of ivermectin tablets have sent onchocerciasis rates plummeting. The village of Beposo 2 in central Ghana is one of those places…” (Beaubien, 1/15).

NPR: The Farmer And Fisherman Who Lost His Sight To River Blindness
“…[60-year-old Emmanuel Kwame, who’s completely blind,] is well aware his life would have been very different if these drugs had come earlier. He says the worst thing about onchocerciasis was that it hit him when he was in his 20s and robbed him of the chance to marry…” (Beaubien, 1/14).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.